ERBB2 and breast cancer: Gene amplification or protein overexpression of the human epidermal growth factor receptor type 2 (HER2) has been reported in ∼20% of invasive breast cancer (BC) and is usually associated with worse prognosis (Slamon et al., 1987, 1989).